Some prescribers step the dose down rather than stopping outright, smoothing the return of appetite further, and evidence across the drug class suggests some weight regain is common after stopping, so agreeing in advance what would prompt a return to treatment removes the sting from that possibility
"We've obviously been working in this category of medicines for a while with the first GLP-1 medication 20 years ago and improving ever since
167,168 In hepatocytes, elevated lipid load and insulin resistance increase mitochondrial -oxidation activity, accompanied by electron leakage and respiratory chain disruption, resulting in substantial ROS production, which exacerbates lipid peroxidation, autophagic dysfunction, and pyroptosis
These methodologic considerations gain particular clinical relevance when examining the study's safety findings